These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089 [TBL] [Abstract][Full Text] [Related]
27. [Therapeutic implications of endothelin antagonists for cardiovascular diseases]. Abassi Z; Ramadan R; Schwartz H; Hoffman A Harefuah; 2004 Jan; 143(1):47-53, 84. PubMed ID: 14748289 [TBL] [Abstract][Full Text] [Related]
28. Bosentan in essential hypertension. Haynes WG; Ferro CJ; Webb DJ N Engl J Med; 1998 Jul; 339(5):346; author reply 347. PubMed ID: 9696644 [No Abstract] [Full Text] [Related]
29. Regulation of aldosterone secretion in patients with chronic congestive heart failure by endothelins. Sütsch G; Bertel O; Rickenbacher P; Clozel M; Yandle TG; Nicholls MG; Kiowski W Am J Cardiol; 2000 Apr; 85(8):973-6. PubMed ID: 10760337 [TBL] [Abstract][Full Text] [Related]
30. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist. Zimmermann M; Seifert V; Löffler BM; Stolke D; Stenzel W Neurosurgery; 1996 Jan; 38(1):115-20. PubMed ID: 8747959 [TBL] [Abstract][Full Text] [Related]
31. Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. Zuccarello M; Soattin GB; Lewis AI; Breu V; Hallak H; Rapoport RM J Neurosurg; 1996 Mar; 84(3):503-7. PubMed ID: 8609565 [TBL] [Abstract][Full Text] [Related]
32. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008]. Cacoub P; Amoura Z; Langleben D Rev Med Interne; 2008 Apr; 29(4):283-9. PubMed ID: 18243424 [TBL] [Abstract][Full Text] [Related]